Reducing the risk of flare-ups and worsened breathing problems in certain patients with severe chronic obstructive pulmonary disease (COPD). Daliresp is a phosphodiesterase type 4 (PDE4) inhibitor. Exactly how it works is not known.
Daliresp is prescribed to prevent symptoms of chronic obstructive pulmonary disease from worsening. Individuals who experience wheezing or shortness of breath may find relief when taking this medication. Daliresp is to be taken on a long-term basis to relieve symptoms. This medicine is available in a tablet form and requires a prescription.
Daliresp (roflumilast) is a medication that is used to control and prevent symptoms of wheezing and shortness of breath that is usually caused by lung diseases. It is mostly used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with other medications.
Daliresp works by reducing the swelling and irritation of the airways to control and prevent COPD symptoms. The drug does not work immediately and so should be used regularly for it to be effective. Daliresp can also be used with other medications such as salmeterol and ipratropium to make it more effective.
The drug should be administered orally once a day with or without food. The age of the patient should be considered while prescribing the dosage.